Important Notices

Irbesartan and Irbesartan with Hydrochlorothiazide (HCTZ) – Specific lots from Lupin Pharmaceuticals

Lupin Pharmaceuticals Inc. is voluntarily recalling certain lots of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. As part of Lupin’s ongoing assessment, analysis revealed that certain tested batches were above the specification limit for the impurity, N-nitrosoirbesartan. Learn more

Lidocaine HCL Topical Solution 4% 50mL – Teligent Pharma Recall of specific lot numbers

Teligent Pharma, Inc. is voluntarily recalling specific lots of Lidocaine HCl Topical Solution 4%, 50ml in a screw cap glass bottle to the patient level. The product is being recalled because the testing has found it to be super potent based on an Out of Specification (OOS) result obtained at the 18-month stability timepoint. Learn more

Glucagon Emergency Kit – Recall of One Lot by Eli Lilly

Eli Lilly is conducting a voluntary nationwide recall of one lot of Glucagon Emergency Kit for Low Blood Sugar to the patient level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder form. Learn more

Losartan and Losartan/HCTZ market withdrawal – Jubilant Cadista Pharmaceuticals

Jubilant Cadista Pharmaceuticals announced a market withdrawal of all unexpired lots of Losartan Potassium as well as Losartan Potassium and Hydrochlorothiazide distributed under the Cadista label. Learn more